David M. Sabatini

8 ta ish

Massachusetts Institute of Technology

1. The Protein Synthesis Inhibitor Blasticidin S Enters Mammalian Cells via Leucine-rich Repeat-containing Protein 8D

   Clarissa C. Lee, Elizaveta Freinkman, David M. Sabatini +1

   MaqolaOAOchiq kirish20145 iqtibos

   ABIABI:AkademIndex/2026.other.040799

2. mTOR Signaling in Growth, Metabolism, and Disease

   Robert A. Saxton, David M. Sabatini

   Sharh maqolaOAOchiq kirish20173 iqtibos

   ABIABI:AkademIndex/2026.other.003109

3. Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton

   Dos D. Sarbassov, Siraj M. Ali, Do‐Hyung Kim +5

   MaqolaOAOchiq kirish20042 iqtibos

   ABIABI:AkademIndex/2026.other.002988

4. mTOR Signaling in Growth Control and Disease

   Mathieu Laplante, David M. Sabatini

   Sharh maqolaOAOchiq kirish20122 iqtibos

   ABIABI:AkademIndex/2026.other.003034

5. Identification and characterization of essential genes in the human genome

   Timothy C. Wang, Kıvanç Birsoy, Nicholas W. Hughes +5

   MaqolaOAOchiq kirish20152 iqtibos

   ABIABI:AkademIndex/2026.other.040765

6. Growing roles for the mTOR pathway

   Dos D. Sarbassov, Siraj M. Ali, David M. Sabatini

   Sharh maqola20052 iqtibos

   ABIABI:AkademIndex/2026.other.227056

7. Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

   Dos D. Sarbassov, David A. Guertin, Siraj M. Ali +1

   Maqola20052 iqtibos

   ABIABI:AkademIndex/2026.other.227153

8. Histidine catabolism is a major determinant of methotrexate sensitivity

   Naama Kanarek, Heather R. Keys, Jason R. Cantor +7

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.889918